Pharmalys Ltd

04/03/2026

Recent studies from the MVPE-CC consortium show that a four-dose RTS,S (Mosquirix) schedule provides stronger protection against severe malaria in children than a three-dose regimen. With successful pilot programmes in , , and , and 24 African countries now including malaria vaccines in routine immunisation, completing all four doses is key to saving lives – a clear win for and the fight against .

The MVPE-CC consortium contributed key evidence reviewed in a joint session of the WHO’s Strategic Advisory Group of Experts on Immunisation (SAGE) and Malaria Policy Advisory Group (MPAG) held in September 2025 for considerations of malaria vaccination schedules in perennial settings. The conclus...

02/03/2026

After decades of stalled progress, breakthroughs in , , and genetic tools are helping protect children, especially those under 5 in from malaria. From new childhood vaccines like and , to infant-specific treatments and methods tracking drug-resistant parasites, science is finally outpacing the parasite’s adaptability. A promising step toward a childhood.

After decades of stalled progress, new vaccines, treatments and genetic tools are helping scientists protect children and save lives worldwide.

28/02/2026

Through free screening and treatment, mobile clinics reaching even the most remote communities, and strong collaboration with the , Burkina Faso is overcoming financial and geographic barriers to healthcare. In just one year, thousands of women were screened, showing that with political commitment and community engagement, can move from vision to reality.

Ouagadougou ‒ “When I heard the town crier announce that health workers were coming for free screening, I felt afraid: if they told me I had the disease, how would I get treated? But I thought of my children and decided to go,” says Awa, 48, a mother of six living in Ipendo, in Burkina Faso’...

27/02/2026

We are proud to celebrate the winners of our 2025 Awards Ceremony, recognised during our Annual Meeting in December and recently honoured with a symbolic trophy presentation at our Dakar office.

In the Awards Ceremony, 34 team members were recognised across three key categories. Each winner received a personalised trophy in recognition of their achievement, impact, and contribution to our continued growth.

Read more about it here https://www.pharmalys.com/pharmalys-awards-cereomony-dakar-senegal-2025/

25/02/2026

For the first time in over three years, campaigns are resuming as global supply reaches a critical milestone. With production nearly doubled since 2022, countries including , , and the are restarting life-saving efforts. A strong reminder that collaboration saves lives alongside continued investment in and resilient health systems.

First preventive campaign in over three years launches in Mozambique, with others planned in Bangladesh and the Democratic Republic of the Congo

21/02/2026

On 21 February 2026, International Mother Language Day highlights the importance of multilingual education under the theme “Youth Voices on Multilingual Education.” In a world shaped by migration and technology, linguistic diversity is essential for inclusion, equitable access to learning, and sustainable development.

Read the full article here https://www.pharmalys.com/international-mother-language-day-2026-multilingual-education/

Nations UNESCO

International Mother Language Day 2026 highlights youth voices on multilingual education, promoting linguistic diversity, inclusion, and equitable access to learning worldwide.

16/02/2026

and the have strengthened their partnership with a new agreement to boost financing for and primary healthcare, support resilient health systems, and advance regional vaccine manufacturing in , mobilising $2 billion over the next five years to help countries achieve sustainable, high-quality health coverage.

World Bank Group and Gavi sign a new MoU to strengthen immunisation, primary healthcare and regional vaccine manufacturing.

14/02/2026

In this podcast, Ester in t’Groen from Johnson & Johnson shares highlights from the ASH Annual Meeting, discuss J&J’s hematology portfolio, explore real world evidence from clinical trials, and preview the company’s key advances and upcoming readouts for 2026.

Welcome to our final episode for 2025. We’re taking a little break for the holidays but we’ll be back again on Friday 9th of January to kick off our year with the Managing Director of Merck KGaA’s M Ventures, Hakan Goker.Today, though, I’m joined ...

13/02/2026

We are pleased to share another successful GCLP audt at the KEMRI - Wellcome Trust in Kilifi, Kenya.

Conducted in November 2025, this audit reflects the laboratory’s commitment to quality, regulatory compliance, and excellence in clinical research. A big congratulations to the team!

Pharmalys completes another successful GCLP audit of the KEMRI–Wellcome Trust Research Programme Kilifi, supporting global GCLP accreditation standards.

12/02/2026

Dr N’da Konan Michel Yao has officially assumed his role as to after presenting his credentials to the Government, marking a new chapter in the longstanding partnership between Senegal and the .

The ceremony demonstrated a shared commitment to strengthening collaboration on national health priorities, advancing universal health coverage, and building a more resilient health system aligned with Senegal’s Vision 2050 and global public health goals.

Dakar – Le Dr N’da Konan Michel Yao, nouveau Représentant résident de l’Organisation mondiale de la Santé (OMS) au Sénégal, a officiellement présenté, ce jour, ses lettres de créance à Son Excellence Monsieur Cheikh Niang, Ministre de l'Intégration africaine, des Affaires étrangère...

11/02/2026

The has prequalified the first two rapid detection tests for , marking a major regulatory milestone that strengthens long term access to quality assured, affordable diagnostics and supports continued global preparedness and response to .

On 17 December 2025, WHO announced the prequalification of two rapid antigen diagnostic tests (Ag-RDT) for SARS-CoV-2: SD Biosensor STANDARD Q COVID-19 Ag Test and; ACON Biotech Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing).

09/02/2026

is increasingly essential for understanding biological processes as they happen, and has emerged as a powerful tool to make this possible. This article explores how spectroscopic techniques enable non-invasive, rea time analysis across healthcare, environmental monitoring and biotechnology, outlining key methods, practical applications, current limitations and future advances shaping faster, data-driven decision-making.

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, environmental monitoring, and bioprocessing.